• Markets
    • icon
  • Companies
4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.96

 0.0 (0.0%)
ASX:Live
07/12/2023 12:00:00 AM
HALO Price Momentum HALO Ords HALO Momentum HALO Earnings Momentum GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

4DX Overview

4DX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About 4DX

Website

4DMedical Ltd

Telephone

61.3.9545.5940

Address

700 Swanston Street Level 7 Carlton, Victoria (VIC) 3053

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$330.98M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.29 - 1.27

Trade Value (12mth)

AU$133,847.00

1 week

-1.55%

1 month

109.89%

YTD

141.77%

1 year

122.09%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

26.400%

EBITDA Margin

%

Operating Cashflow

-$23m

Free Cash Flow Return

-32.30%

ROIC

-44.80%

Interest Coverage

-142.90

Quick Ratio

4.60

Other Data

Shares on Issue (Fully Dilluted)

306m

HALO Sector

Technology

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

4DX Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activity Report and Appendix 4C for Q1 FY2024

×

Quarterly Activity Report and Appendix 4C for Q1 FY2024

31 May 23

Change in substantial holding

×

Change in substantial holding

31 May 23

Change in substantial holding

×

Change in substantial holding

31 May 23

Change in substantial holding

×

Change in substantial holding

31 July 23

Quarterly Activity Report and Appendix 4C for Q4 FY2023

×

Quarterly Activity Report and Appendix 4C for Q4 FY2023

31 January 23

Quarterly Activity Report and Appendix 4C for Q2 FY2023

×

Quarterly Activity Report and Appendix 4C for Q2 FY2023

31 January 22

Quarterly Activity Report and Appendix 4C for Q2 FY2022

×

Quarterly Activity Report and Appendix 4C for Q2 FY2022

31 August 22

Vanderblit 'burn pit' trial hits primary endpoint

×

Vanderblit 'burn pit' trial hits primary endpoint

31 August 21

2021 Annual General Meeting

×

2021 Annual General Meeting

30 September 22

2022 Annual Report

×

2022 Annual Report

30 September 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 October 23

4DMedical enters contract with Integral Diagnostics

×

4DMedical enters contract with Integral Diagnostics

30 November 23

4DMedical Webinar

×

4DMedical Webinar

30 May 23

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

29 November 23

4DMedical and Philips sign Memorandum of Understanding

×

4DMedical and Philips sign Memorandum of Understanding

29 November 22

4DMedical receives $9.4m from MRFF

×

4DMedical receives $9.4m from MRFF

29 May 23

4DMedical completes oversubscribed $25m SPP

×

4DMedical completes oversubscribed $25m SPP

29 May 23

Update - Proposed issue of securities - 4DX

×

Update - Proposed issue of securities - 4DX

29 August 23

Annual Report and Appendix 4E

×

Annual Report and Appendix 4E

29 August 23

FY2023 Full Year Results

×

FY2023 Full Year Results

29 August 23

Corporate Governance Statement

×

Corporate Governance Statement

29 August 23

Appendix 4G

×

Appendix 4G

29 August 23

Notice of AGM Date

×

Notice of AGM Date

29 April 22

Quarterly Activity Report and Appendix 4C for Q3 FY2022

×

Quarterly Activity Report and Appendix 4C for Q3 FY2022

28 September 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 September 21

2021 Notice of Annual General Meeting

×

2021 Notice of Annual General Meeting

28 October 22

Quarterly Activity Report - Clarification

×

Quarterly Activity Report - Clarification

28 October 21

2021 Annual General Meeting presentation

×

2021 Annual General Meeting presentation

4DX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.08 -0.08 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.08 -0.08 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.3 -2.0 -25.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.06 -0.08 -0.08 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.09 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.8 -17.6 -4.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -4.7 -16.1 -11.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.28 0.20 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.27 0.18 0.19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 574.0 -31.5 4.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 261 295 300 Lock Lock Lock
Basic m Lock Lock Lock Lock 261 295 300 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -82.4 385.9 -31.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 16 20 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -12 -20 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.1 -69.6 -18.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -5,551.4 -1,937.8 -3,378.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 5,651 2,038 3,479 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -24 -35 -42 Lock Lock Lock
     Growth % Lock Lock Lock Lock -53.5 -49.4 -19.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -10,875.4 -3,343.9 -5,845.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -24 -37 -45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -52.5 -51.0 -21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11,217.2 -3,485.8 -6,202.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -25 -28 -37 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -4 -5 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -21 -25 -31 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -14.8 -27.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9,872.2 -2,332.6 -4,378.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -15 -25 -23 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 4 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -4 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 88 -1 43 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -15 -28 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -89.3 -84.9 17.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -69.6 -26.5 -32.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 81 51 70 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 93 74 93 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 5 4 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -79 -45 -64 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 9 15 21 Lock Lock Lock
Equity $m Lock Lock Lock Lock 83 60 71 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 84 65 76 Lock Lock Lock
     Growth % Lock Lock Lock Lock 853.6 -23.3 17.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -23.1 -33.1 -33.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -54.3 -48.7 -62.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -58.6 -33.0 -44.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -39.7 -33.9 -32.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -8.8 -196.3 -142.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.4 1.3 1.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -95.0 -75.4 -90.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 10.5 6.2 4.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 10.5 6.2 4.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 94.2 86.8 88.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -177.8 -264.4 -132.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.1 0.2 0.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 144.8 277.4 75.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 206.6 171.7 398.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -11,740.8 -2,666.9 -5,093.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -27.5 -37.8 -39.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -23.1 -33.1 -33.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 2.5 1.3 4.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 4,828.0 1,792.8 3,385.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 4,830.5 1,794.1 3,390.2 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 31.1 19.3 33.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 4,799.4 1,774.8 3,356.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.01%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.96.
The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$1.27.
The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.29.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) has a franking level of 0%.
4DMedical Ltd (4DX:ASX) is classified in the Technology.
The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.